Immuno-Oncology 360°

grace@tcfllc.org
02/01/2017 - 02/03/2017 The Roosevelt Hotel, New York

The 3rd annual Immuno-Oncology 360° is the only conference that provides a unique 360-degree approach addressing the most-up-to-date information regarding business aspects, clinical advancements and scientific data that will help accelerate clinical trials and FDA approval, ultimately transforming the way cancer is treated. Designed by lead advisors and co-chair’s Dr. Axel Hoos (GSK) and Dr. James Gulley (NCI) along with the support of the Cancer Research Institute (CRI), The Society for Immunotherapy of Cancer (SITC) and The Association of Cancer Immunotherapy (CIMT).